Key Highlights
- Prucka 3 with CardioLab EP Recording System enhances diagnosis and treatment of cardiac arrhythmias like AFib.
- New features include enhanced signal filtering, dual real-time displays, and ClearMatch for morphology comparison.
- Built on 20+ years of EP lab success, offering high signal fidelity and advanced analytics.
Source: Business Wire
Notable Quotes
- “Signal clarity is key in the EP Lab,” – Dr. Usman Siddiqui, Director at Electrophysiology
- “The latest Prucka 3 digital amplifier…‘amplifies’ the EP Lab experience,” – Devon Bream, General Manager of Invasive Cardiology at GE HealthCare
- “EP recording systems…are critical to enabling advanced technologies in EP,” – Dr. Saumil Oza, Director at Electrophysiology
SoH's Take
The introduction of the Prucka 3 with CardioLab EP Recording System by GE HealthCare marks a significant advancement in the field of electrophysiology, addressing the critical need for accurate diagnosis and treatment of cardiac arrhythmias, such as atrial fibrillation. With cardiovascular disease remaining the global leader in mortality, innovations like Prucka 3 are crucial in the battle against these life-threatening conditions. This system not only offers unparalleled signal clarity and advanced analytics but also demonstrates GE HealthCare’s ongoing commitment to improving patient outcomes through technological excellence. As the prevalence of atrial fibrillation continues to rise, the role of sophisticated recording systems in electrophysiology labs becomes ever more vital. GE HealthCare’s Prucka 3 is set to redefine the standards of cardiac care, ensuring that clinicians have access to the best tools for diagnosing and treating cardiac arrhythmias effectively.
